{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:23:27Z","timestamp":1790753007971,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development","award":["K23 HD090993 (J.D.O.)"],"award-info":[{"award-number":["K23 HD090993 (J.D.O.)"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clinthera.2018.05.016","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T15:40:04Z","timestamp":1530805204000},"page":"1255-1267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3625-5174","authenticated-orcid":false,"given":"Jodie","family":"Dionne-Odom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Njei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.N.","family":"Tita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.05.016_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120922","article-title":"Inequalities in maternal health care utilization in sub-Saharan African countries: a multiyear and multi-country analysis","volume":"10","author":"Alam","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0002","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3855\/jidc.3243","article-title":"Hepatitis B and C virus infections among pregnant women in Arab and African countries","volume":"7","author":"Gasim","year":"2013","journal-title":"Journal of infection in developing countries"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0003","doi-asserted-by":"crossref","first-page":"18871","DOI":"10.7448\/IAS.17.1.18871","article-title":"Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa","volume":"17","author":"Hoffmann","year":"2014","journal-title":"Journal of the International AIDS Society"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jvh.12263","article-title":"Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges","volume":"21","author":"Howell","year":"2014","journal-title":"Journal of viral hepatitis"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2334-12-131","article-title":"The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions","volume":"12","author":"Ott","year":"2012","journal-title":"BMC infectious diseases"},{"issue":"10003","key":"10.1016\/j.clinthera.2018.05.016_bib0006","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"10049","key":"10.1016\/j.clinthera.2018.05.016_bib0007","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0008","series-title":"Sustainable Development Goals","year":"2015"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0009","unstructured":"World Health Organization. Combating Hepatitis B and C to Reach Elimination by 2030. http:\/\/www.who.int\/hepatitis\/publications\/hep-elimination-by-2030-brief\/en\/."},{"key":"10.1016\/j.clinthera.2018.05.016_bib0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","article-title":"Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets","volume":"2","author":"Spearman","year":"2017","journal-title":"The lancet gastroenterology & hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0011","doi-asserted-by":"crossref","unstructured":"Ward JW. Building the evidence base to eliminate hepatitis B and C as public health threats. The lancet infectious diseases.16:1314-1316.","DOI":"10.1016\/S1473-3099(16)30272-9"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0012","doi-asserted-by":"crossref","unstructured":"Wong GL-H, Wong VW-S. Eliminating hepatitis B virus as a global health threat. The lancet infectious diseases.16:1313-1314.","DOI":"10.1016\/S1473-3099(16)30214-6"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0013","article-title":"Hepatitis B vaccines: WHO position paper, July 2017\u2014Recommendations","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0014","first-page":"369","article-title":"Hepatitis B vaccines: WHO position paper\u2014July 2017","volume":"92","year":"2017","journal-title":"Releve epidemiologique hebdomadaire"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2018.05.016_bib0015","first-page":"17","article-title":"The status of hepatitis B control in the African region","volume":"27","author":"Breakwell","year":"2017","journal-title":"The Pan African medical journal"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0016","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12072-017-9825-y","article-title":"Viral factors for HBV mother to child transmission","volume":"11","author":"Park","year":"2017","journal-title":"Hepatology international"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121632","article-title":"Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials","volume":"10","author":"Tran","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0018","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.cgh.2013.04.026","article-title":"Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants","volume":"11","author":"Pan","year":"2013","journal-title":"Clinical gastroenterology and hepatolog: the official clinical practice journal of the American Gastroenterological Association"},{"key":"10.1016\/j.clinthera.2018.05.016_sbref0016","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12884-017-1487-1","article-title":"Cesarean section to prevent mother to child transmission of hepatitis B virus in China: A meta-analysis","volume":"17","author":"Yang","year":"2017","journal-title":"BMC pregnancy and childbirth"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajog.2015.09.100","article-title":"#38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission","volume":"214","author":"Dionne-Odom","year":"2016","journal-title":"American journal of obstetrics and gynecology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0021","doi-asserted-by":"crossref","unstructured":"Liu J, Zhang S, Liu M, Wang Q, Shen H, Zhang Y. Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study. The lancet global health.5:e624-e632.","DOI":"10.1016\/S2214-109X(17)30142-0"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14218\/JCTH.2016.00067","article-title":"Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis","volume":"5","author":"Mavilia","year":"2017","journal-title":"Journal of clinical and translational hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0023","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/apt.13795","article-title":"Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa","volume":"44","author":"Keane","year":"2016","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0024","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MCG.0000000000000908","article-title":"Management of chronic hepatitis B in pregnancy","volume":"51","author":"Li","year":"2017","journal-title":"Journal of clinical gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2018.05.016_bib0025","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/jpids\/piu064","article-title":"Prevention of perinatal hepatitis B virus transmission","volume":"3","author":"Nelson","year":"2014","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0026","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/01443610600963986","article-title":"Risk factors for hepatitis B infection during pregnancy in a Nigerian obstetric population","volume":"26","author":"Obi","year":"2006","journal-title":"Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2013.02.015","article-title":"Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention","volume":"59","author":"Wen","year":"2013","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0028","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1743-422X-5-100","article-title":"Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus\u2014a systematic review","volume":"5","author":"Yang","year":"2008","journal-title":"Virology journal"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0029","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.vaccine.2013.01.020","article-title":"Economic evaluation of universal newborn hepatitis B vaccination in China","volume":"31","author":"Lu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0030","doi-asserted-by":"crossref","first-page":"djv273","DOI":"10.1093\/jnci\/djv273","article-title":"Long-term realism and cost-effectiveness: primary prevention in combatting cancer and associated inequalities worldwide","volume":"107","author":"Bray","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0031","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1477-7819-12-246","article-title":"Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting","volume":"12","author":"Jaka","year":"2014","journal-title":"World journal of surgical oncology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0032","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2016.10.013","article-title":"Battlefield against hepatitis B infection and HCC in Africa","volume":"66","author":"Lemoine","year":"2017","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0033","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.annepidem.2009.01.017","article-title":"Rocks along the road to the control of HBV and HCC","volume":"19","author":"Beasley","year":"2009","journal-title":"Annals of epidemiology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0034","article-title":"Hepatitis B virus infection as a neglected tropical disease","volume":"11","author":"O'Hara","year":"2017","journal-title":"PLoS neglected tropical diseases"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15585\/mmwr.mm6701a6","article-title":"Status of HIV epidemic control among adolescent girls and young women aged 15-24 years\u2014seven African countries, 2015-2017","volume":"67","author":"Brown","year":"2018","journal-title":"MMWR Morbidity and mortality weekly report"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0036","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMp1201796","article-title":"HIV-HBV coinfection\u2014a global challenge","volume":"366","author":"Kourtis","year":"2012","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0037","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/cix122","article-title":"Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia","volume":"64","author":"Vinikoor","year":"2017","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0038","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/QAI.0000000000001618","article-title":"HBV or HCV coinfection in HIV-1-infected pregnant women in France: prevalence and pregnancy outcomes","volume":"77","author":"Benhammou","year":"2018","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0039","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/hiv.12120","article-title":"Impact of maternal hepatitis B virus coinfection on mother to child transmission of HIV","volume":"15","author":"Mave","year":"2014","journal-title":"HIV medicine"},{"issue":"6","key":"10.1016\/j.clinthera.2018.05.016_bib0040","first-page":"373","article-title":"Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"The lancet Gastroenterology & hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0041","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/infdis\/jiy028","article-title":"Call to action: prevention of mother-to-child transmission of hepatitis B in Africa","volume":"217","author":"Wilson","year":"2018","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0042","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MEG.0000000000000559","article-title":"Short article: hepatitis B virus status in children born to HIV\/HBV coinfected women in a French hospital: a cross-sectional study","volume":"28","author":"Sellier","year":"2016","journal-title":"European journal of gastroenterology & hepatology"},{"issue":"suppl_8","key":"10.1016\/j.clinthera.2018.05.016_bib0043","doi-asserted-by":"crossref","first-page":"S785","DOI":"10.1093\/infdis\/jix429","article-title":"Management of pregnant women and children: focusing on preventing mother-to-infant transmission","volume":"216","author":"Chen","year":"2017","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0044","doi-asserted-by":"crossref","first-page":"174","DOI":"10.11604\/pamj.2017.28.174.10971","article-title":"Knowledge, attitude and practice of staff of 4 hospitals in Yaounde on the prevention of vertical transmission of hepatitis B","volume":"28","author":"Paul","year":"2017","journal-title":"The Pan African medical journal"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2016\/4359401","article-title":"Hepatitis B, HIV, and Syphilis seroprevalence in pregnant women and blood donors in Cameroon","volume":"2016","author":"Dionne-Odom","year":"2016","journal-title":"Infectious diseases in obstetrics and gynecology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0046","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ijgo.12434","article-title":"A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination","author":"Anderson","year":"2018","journal-title":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0047","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/INF.0000000000001728","article-title":"Predictors of infant hepatitis B immunization in Cameroon: data to Inform Implementation of a hepatitis B birth dose","volume":"37","author":"Dionne-Odom","year":"2018","journal-title":"The pediatric infectious disease journal"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0048","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jmv.24409","article-title":"HBV carriage in children born from HIV-seropositive mothers in Senegal: the need of birth-dose HBV vaccination","volume":"88","author":"Gueye","year":"2016","journal-title":"Journal of medical virology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0049","first-page":"610","article-title":"Preventing hepatitis B and hepatocellular carcinoma in South Africa: the case for a birth-dose vaccine","volume":"104","author":"Spearman","year":"2014","journal-title":"South African medical journal\u202f=\u202fSuid-Afrikaanse tydskrif vir geneeskunde"},{"key":"10.1016\/j.clinthera.2018.05.016_sbref0046","series-title":"Vaccine Coverage Estimates","year":"2016"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0051","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/01443615.2012.711389","article-title":"Knowledge of hepatitis B virus infection, access to screening and vaccination among pregnant women in Ibadan, Nigeria","volume":"33","author":"Adeyemi","year":"2013","journal-title":"Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0052","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s13104-017-2702-x","article-title":"Seroprevalence of Hepatitis B virus surface antigen and factors associated among pregnant women in Dawuro zone, SNNPR, southwest Ethiopia: a cross sectional study","volume":"10","author":"Chernet","year":"2017","journal-title":"BMC research notes"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0053","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2016027","article-title":"Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study","volume":"38","author":"Metaferia","year":"2016","journal-title":"Epidemiology and health"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181267","article-title":"Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: a South African experience","volume":"12","author":"Chotun","year":"2017","journal-title":"PLoS One"},{"issue":"RR-1","key":"10.1016\/j.clinthera.2018.05.016_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR recommendations and reports: morbidity and mortality weekly report recommendations and reports"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0056","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.vaccine.2016.04.042","article-title":"The immunogenicity in healthy infants and efficiency to prevent mother to child transmission of hepatitis B virus of a 10mug recombinant yeast-derived hepatitis B vaccine (Hep-KSC)","volume":"34","author":"Zhu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0057","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/14760584.2017.1338569","article-title":"The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience","volume":"16","author":"van den Ende","year":"2017","journal-title":"Expert review of vaccines"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0058","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2012.12.012","article-title":"Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review","volume":"31","author":"Schillie","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0059","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1097\/INF.0000000000001578","article-title":"Serologic responses after hepatitis B vaccination in preterm infants born to hepatitis B surface antigen-positive mothers: Singapore experience","volume":"36","author":"Tan","year":"2017","journal-title":"The pediatric infectious disease journal"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.15585\/mmwr.mm6605e1","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger \u2014United States, 2017","volume":"66","author":"Robinson","year":"2017","journal-title":"MMWR Morbidity and mortality weekly report"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0061","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fimmu.2018.00328","article-title":"The effect of human immunodeficiency virus and cytomegalovirus infection on infant responses to vaccines: a review","volume":"9","author":"Falconer","year":"2018","journal-title":"Frontiers in immunology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0062","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4161\/hv.5.8.8600","article-title":"A heat-stable hepatitis B vaccine formulation","volume":"5","author":"Jezek","year":"2009","journal-title":"Human vaccines"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0063","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-14-7","article-title":"Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program","volume":"14","author":"Peto","year":"2014","journal-title":"BMC infectious diseases"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0064","doi-asserted-by":"crossref","first-page":"e1500","DOI":"10.1542\/peds.2013-2940","article-title":"Duration of protection after infant hepatitis B vaccination series","volume":"133","author":"Middleman","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0065","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4161\/hv.24844","article-title":"Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand","volume":"9","author":"Poovorawan","year":"2013","journal-title":"Human vaccines & immunotherapeutics"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0066","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.scitotenv.2010.09.036","article-title":"Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa","volume":"423","author":"Hennig","year":"2012","journal-title":"The Science of the total environment"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0067","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0068","doi-asserted-by":"crossref","first-page":"ofx225","DOI":"10.1093\/ofid\/ofx225","article-title":"Comparative effectiveness of prophylactic strategies for perinatal transmission of hepatitis B virus: a network meta-analysis of randomized controlled trials","volume":"4","author":"Chen","year":"2017","journal-title":"Open forum infectious diseases"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004790.pub2","article-title":"Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers","author":"Lee","year":"2006","journal-title":"The Cochrane database of systematic reviews"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0070","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.vaccine.2008.03.018","article-title":"A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire","volume":"26","author":"Ekra","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0071","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2017.04.020","article-title":"Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda","volume":"35","author":"Seremba","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0072","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1016\/j.vaccine.2015.09.058","article-title":"Hepatitis B virus infection in northern Uganda: impact of pentavalent hepatitis B vaccination","volume":"33","author":"Teshale","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2018.05.016_bib0073","first-page":"18","article-title":"Is hepatitis B birth dose vaccine needed in Africa","volume":"27","author":"Tamandjou","year":"2017","journal-title":"The Pan African medical journal"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0074","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of hepatitis B virus infection and impact of vaccination on disease","volume":"20","author":"Nelson","year":"2016","journal-title":"Clinics in liver disease"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0075","doi-asserted-by":"crossref","unstructured":"Nayagam S, Thursz M, Sicuri E, et al. Requirements for global elimination of hepatitis B: a modelling study. The lancet infectious diseases.16:1399-1408.","DOI":"10.1016\/S1473-3099(16)30204-3"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0076","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.vaccine.2017.11.004","article-title":"Hepatitis B infection control in Colombian Amazon after 15years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence","volume":"36","author":"Garcia","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0077","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.vaccine.2018.03.028","article-title":"Long-term immunity to hepatitis B following vaccination in infancy: real-world data analysis","volume":"36","author":"Klinger","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0078","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4269\/ajtmh.15-0121","article-title":"Hepatitis B virus infection in Indonesia 15 years after adoption of a universal infant vaccination program: possible impacts of low birth dose coverage and a vaccine-escape mutant","volume":"95","author":"Purwono","year":"2016","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2018.05.016_bib0079","first-page":"19","article-title":"Delayed introduction of the birth dose of hepatitis B vaccine in EPI programs in East Africa: a missed opportunity for combating vertical transmission of hepatitis B","volume":"27","author":"Bodo","year":"2017","journal-title":"The Pan African medical journal"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0080","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.vaccine.2016.05.017","article-title":"Barriers to timely administration of birth dose vaccines in The Gambia, West Africa","volume":"34","author":"Miyahara","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0081","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.vaccine.2016.03.060","article-title":"Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014","volume":"34","author":"Wiesen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0082","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.1995.03530150025029","article-title":"Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations","volume":"274","author":"Margolis","year":"1995","journal-title":"Jama"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0083","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/heapol\/czy018","article-title":"The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up","volume":"33","author":"Hecht","year":"2018","journal-title":"Health policy and planning"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0084","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.vaccine.2015.11.044","article-title":"Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014","volume":"34","author":"Wiesen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12889-016-3215-6","article-title":"Mother to child transmission of hepatitis B: extent of knowledge of physicians and midwives in Eastern region of Ghana","volume":"16","author":"Adjei","year":"2016","journal-title":"BMC public health"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0086","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vaccine.2017.11.027","article-title":"Status and progress of hepatitis B control through vaccination in the South-East Asia region, 1992-2015","volume":"36","author":"Childs","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0087","doi-asserted-by":"crossref","first-page":"J36","DOI":"10.1016\/j.vaccine.2012.11.061","article-title":"Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation","volume":"31 Suppl 9","author":"Cui","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0088","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1016\/j.vaccine.2013.11.097","article-title":"Findings from a hepatitis B birth dose assessment in health facilities in the Philippines: opportunities to engage the private sector","volume":"32","author":"Patel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0089","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/1471-0528.14422","article-title":"Does place and attendance at birth improve early neonatal mortality? Secondary analysis of nine Demographic and Health Surveys","volume":"124","author":"Bellizzi","year":"2017","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4755-12-6","article-title":"Drivers of facility deliveries in Africa and Asia: regional analyses using the demographic and health surveys","volume":"12","author":"Diamond-Smith","year":"2015","journal-title":"Reproductive health"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0091","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1016\/j.vaccine.2017.06.056","article-title":"Improving hepatitis B birth dose coverage through village health volunteer training and pregnant women education","volume":"35","author":"Li","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0092","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1016\/j.vaccine.2016.09.056","article-title":"Improving hepatitis B birth dose in rural Lao People's Democratic Republic through the use of mobile phones to facilitate communication","volume":"34","author":"Xeuatvongsa","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0093","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/j.vaccine.2009.05.069","article-title":"Characterization of a thermostable hepatitis B vaccine formulation","volume":"27","author":"Braun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0094","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2006.74.255","article-title":"Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam","volume":"74","author":"Hipgrave","year":"2006","journal-title":"The American journal of tropical medicine and hygiene"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0264-410X(92)90064-Q","article-title":"Heat stability of a recombinant DNA hepatitis B vaccine","volume":"10","author":"Van Damme","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0096","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1016\/j.vaccine.2016.03.080","article-title":"Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR","volume":"34","author":"Kolwaite","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0097","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2471\/BLT.04.017426","article-title":"Improving birth dose coverage of hepatitis B vaccine","volume":"84","author":"Hipgrave","year":"2006","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0098","doi-asserted-by":"crossref","first-page":"e596","DOI":"10.1016\/S2214-109X(18)30233-X","article-title":"Game changing: hepatitis B vaccine in a controlled temperature chain","volume":"6","author":"Patel","year":"2018","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0099","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/S2214-109X(18)30219-5","article-title":"Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study","volume":"6","author":"Scott","year":"2018","journal-title":"The lancet global health"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.vaccine.2017.11.037","article-title":"The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother to child transmission of hepatitis B virus: a prospective cohort study","volume":"36","author":"Wei","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0101","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmv.10071","article-title":"Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants","volume":"67","author":"Milne","year":"2002","journal-title":"Journal of medical virology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vaccine.2016.11.061","article-title":"Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)\/HBeAg (-) mothers","volume":"35","author":"Lu","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0103","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jac\/dku404","article-title":"Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+\/HBeAg- mothers: a systematic review and meta-analysis","volume":"70","author":"Machaira","year":"2015","journal-title":"The journal of antimicrobial chemotherapy"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0104","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/hep.27034","article-title":"Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cgh.2012.01.019","article-title":"Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B","volume":"10","author":"Pan","year":"2012","journal-title":"Clinical gastroenterology and hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0106","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcv.2014.06.005","article-title":"Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus","volume":"61","author":"Yu","year":"2014","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0108","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10096-014-2270-0","article-title":"Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads","volume":"34","author":"Jackson","year":"2015","journal-title":"European journal of clinical microbiology and infectious disease"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0109","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","article-title":"A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection","volume":"55","author":"Han","year":"2011","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0110","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cgh.2014.08.043","article-title":"Telbivudine prevents vertical transmission of hepatitis B virus from women high viral loads: a prospective long-term study","volume":"13","author":"Wu","year":"2015","journal-title":"Clinical gastroenterology and hepatology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0111","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","year":"2018","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0112","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s10620-012-2187-3","article-title":"Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series","volume":"57","author":"Pan","year":"2012","journal-title":"Digestive diseases and sciences"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0113","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0114","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1708131","article-title":"Tenofovir versus placebo to prevent perinatal transmission of hepatitis B","volume":"378","author":"Jourdain","year":"2018","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0115","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/liv.12959","article-title":"Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis","volume":"36","author":"Njei","year":"2016","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0116","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12879-017-2660-x","article-title":"Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis","volume":"17","author":"Devine","year":"2017","journal-title":"BMC infectious diseases"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0117","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/liv.12561","article-title":"Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns","volume":"35","author":"Sellier","year":"2015","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0118","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2169\/internalmedicine.54.3514","article-title":"Factors associated with mother to child transmission of hepatitis B virus despite immunoprophylaxis","volume":"54","author":"Liu","year":"2015","journal-title":"Internal medicine (Tokyo, Japan)"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0119","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1473-3099(15)00158-9","article-title":"Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy","volume":"15","author":"Thio","year":"2015","journal-title":"The lancet infectious diseases"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0120","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1093\/cid\/ciw044","article-title":"Eradication strategies for chronic hepatitis B infection","volume":"62 Suppl 4","author":"Wilson","year":"2016","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0121","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000000877","article-title":"Baseline hepatitis B virus titer predicts initial postpartum hepatic flare: a multicenter prospective study","author":"Liu","year":"2017","journal-title":"Journal of clinical gastroenterology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0122","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MCG.0000000000000822","article-title":"Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis B","volume":"52","author":"Chang","year":"2018","journal-title":"Journal of clinical gastroenterology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0123","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/ajg.2016.296","article-title":"Serum alanine aminotransferase and hepatitis B DNA flares in pregnant and postpartum women with chronic hepatitis B","volume":"111","author":"Chang","year":"2016","journal-title":"The American journal of gastroenterology"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0124","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/liv.13625","article-title":"How to control highly endemic hepatitis B in Asia","volume":"38 Suppl 1","author":"Shan","year":"2018","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.13320","article-title":"Challenges in warranting access to prophylaxis and therapy for hepatitis B virus infection","volume":"37 Suppl 1","author":"Debarry","year":"2017","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0126","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/hep.28310","article-title":"Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection","volume":"63","author":"Fan","year":"2016","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.clinthera.2018.05.016_bib0127","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12879-017-2549-8","article-title":"Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa","volume":"17","author":"Aberra","year":"2017","journal-title":"BMC infectious diseases"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818302467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818302467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T04:54:56Z","timestamp":1604552096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818302467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":127,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0149291818302467"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.05.016","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}